Last updated 5 days ago

Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus

116 patients around the world
Available in Argentina, Chile, United States
Sanofi
7Research sites
116Patients around the world
This study is for people with
Lupus
Systemic lupus erythematosus
Requirements for the patient
To 70 Years
All Gender
Medical requirements
Sites
Sala de Primeros Auxilios Alberto Mignaburu - Berazategui, Prov Buenos Aires
Sala de Primeros Auxilios Alberto Mignaburu - Berazategui, Prov Buenos Aires
Recruiting
Av. Antartida Argentina entre calle 257 y camino Gral Belgrano S/N, Berazategui Buenos Aires
Clínica Adventista Belgrano - CABA - Buenos Aires
Clínica Adventista Belgrano - CABA - Buenos Aires
Recruiting
Estomba 1710, CABA, Buenos Aires
DOM Centro de Reumatología - CABA
Recruiting
Ayacucho 1246, CABA, Buenos Aires
STAT Research - CABA
STAT Research - CABA
Av. Callao 875, CABA, Buenos Aires
Centro de Investigaciones Médicas Tucumán
Recruiting
Lavalle 506, T4000 San Miguel de Tucumán, Tucumán, Argentina
Fundación CIDEA - Buenos Aires
Fundación CIDEA - Buenos Aires
Paraguay 2035, C1121ABE Cdad. Autónoma de Buenos Aires, Argentina
Centro Paulista de Investigação Clínica - CEPIC
Recruiting
R. Moreira e Costa, 342 - Ipiranga, São Paulo - SP, 04266-010
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy